Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

NCT01257399 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis in Remission

Interventions

DRUG: Asacol®
DRUG: Mesalazine

Sponsor

Tillotts Pharma AG

Collaborators

[object Object]